Why are geriatric patients less likely to get treated for their non-melanoma skin cancers? Researchers investigate and report.
The Global Burden of Disease 2017 study found non-melanoma skin cancer to be the biggest increase in incidence worldwide.
Researchers evaluated the response of patients with BCC to fractionated photodynamic therapy at 30 days after treatment.
The authors discuss the potential use and limitations of immunotherapy among patients with squamous cell cancer, basal cell carcinoma, and other skin cancers.
The association between the presence of several viruses and non-melanoma skin cancer was investigated in a recent study.
Researchers evaluated whether treatment with calcipotriol plus 5-fluorouracil aided in reducing the risk of squamous cell carcinoma.
A review published in Experimental Dermatology examined the safety and efficacy of nicotinamide in reducing non-melanoma skin cancers.
Survival rates in patients with cSCC receiving high-dose chemoradiotherapy vs conventional radical surgery were compared.
A recent review article highlighted developments in the treatment of non-melanoma skin cancers, from new chemoprevention agents to telemedicine.
A new meta-analysis offers compelling evidence on the causal relationship between indoor tanning and skin cancer risk.